The CAR T cell revolution in cancer therapy
Dr Grupp meets with ecancertv at Childhood Cancer 2016 to discuss how engineered T cells are changing therapy of paediatric tumours.
He summarises the development of CAR T cells, and introduces a phase II trial due to report results at ASH 2016.
Видео The CAR T cell revolution in cancer therapy канала ecancer
He summarises the development of CAR T cells, and introduces a phase II trial due to report results at ASH 2016.
Видео The CAR T cell revolution in cancer therapy канала ecancer
Показать
Комментарии отсутствуют
Информация о видео
Другие видео канала
![Selective oestrogen receptor degraders as treatment for ER positive/HER2 negative advanced/metas...](https://i.ytimg.com/vi/D5CBf8TI_44/default.jpg)
![Amivantamab combo with lazertinib favourable in post-osimertinib EGFR-mutant NSCLC](https://i.ytimg.com/vi/vPhDzTjFnPw/default.jpg)
![An AI-derived digital pathology-based biomarker to predict the benefit of ADT in PC with validat...](https://i.ytimg.com/vi/hodQmlX-Fng/default.jpg)
![Identifying causing mechanisms in cancers with unknown primary site improves treatment & survival](https://i.ytimg.com/vi/QeUq5seo2gw/default.jpg)
![Regional lymph node irradiation in early breast cancer](https://i.ytimg.com/vi/06w_bZGQlE8/default.jpg)
![Dr. Aizik Wolf -- Cuantas metástasis tratar](https://i.ytimg.com/vi/GeQea4GLaDA/default.jpg)
![Halving duration of ADT for high risk prostate cancer patients](https://i.ytimg.com/vi/mpHB1dhgQ0U/default.jpg)
![Latest advances in mHSPC from ASCO GU 2020](https://i.ytimg.com/vi/thniCdBdCvU/default.jpg)
![ESMO 2017: Prostate cancer highlights](https://i.ytimg.com/vi/-K-QwyjMLmM/default.jpg)
![Targeting CD70 with cusatuzumab eliminates acute myeloid leukaemia stem cells in humans](https://i.ytimg.com/vi/e6n7qAUq7bE/default.jpg)
![Breast cancer highlights from ASCO 2019](https://i.ytimg.com/vi/i-ec1vlYHM4/default.jpg)
![Causes, symptoms, and prevention of skin cancer](https://i.ytimg.com/vi/j_V8u6oP8gc/default.jpg)
![Durvalumab following chemoradiotherapy improves survival in patients with limited-stage small-ce...](https://i.ytimg.com/vi/w6TAqsZU8Xo/default.jpg)
![Phase 3 study shows HER2 therapy clinically meaningful for metastatic breast cancer patients](https://i.ytimg.com/vi/G60tqTLawqA/default.jpg)
![CLL12 trial: Ibrutinib in previously untreated, asymptomatic early-stage CLL](https://i.ytimg.com/vi/rzEJkJNdAiU/default.jpg)
![CLL14: Venetoclax plus obinutuzumab in untreated CLL](https://i.ytimg.com/vi/pZzj0wjfVBg/default.jpg)
![Prostate cancer patients receiving androgen-deprivation therapies shown to be at lower risk from...](https://i.ytimg.com/vi/gfpI8GlwgxE/default.jpg)
![Managing the side effects of CAR T-cell therapy](https://i.ytimg.com/vi/6k78iS43Eko/default.jpg)
![LUMINA results: Women with low levels of the Ki67 biomarker can avoid outcomes related to RT](https://i.ytimg.com/vi/oYh3Vx2rcyw/default.jpg)
![Maintenance chemotherapy extends life for children with rare rhabdomyosarcoma](https://i.ytimg.com/vi/nEleWQKjpxU/default.jpg)